Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.01.2024 | Case report

Tadalafil/vardenafil

Drug induced liver injury

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Xu B, et al. Combination vardenifil and tadalifil drug induced liver injury; case report and review of the literature of liver injury associated with phosphodiesterase type 5 inhibitors. Canadian Liver Journal 6: 363-371, No. 3, Oct 2023. Available from: URL: https://dx.doi.org/10.3138/canlivj-2023-0004 Xu B, et al. Combination vardenifil and tadalifil drug induced liver injury; case report and review of the literature of liver injury associated with phosphodiesterase type 5 inhibitors. Canadian Liver Journal 6: 363-371, No. 3, Oct 2023. Available from: URL: https://​dx.​doi.​org/​10.​3138/​canlivj-2023-0004
Metadaten
Titel
Tadalafil/vardenafil
Drug induced liver injury
Publikationsdatum
01.01.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-52502-x

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Fremanezumab

Case report

Lenvatinib

Case report

Nortriptyline